These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 1776809)
1. A broad spectrum immunoassay using fluorescence polarization for the detection of amphetamines in urine. Turner GJ; Colbert DL; Chowdry BZ Ann Clin Biochem; 1991 Nov; 28 ( Pt 6)():588-94. PubMed ID: 1776809 [TBL] [Abstract][Full Text] [Related]
2. Development and evaluation of an improved method for screening of amphetamines. Shindelman J; Mahal J; Hemphill G; Pizzo P; Coty WA J Anal Toxicol; 1999 Oct; 23(6):506-10. PubMed ID: 10517558 [TBL] [Abstract][Full Text] [Related]
3. Direct stopped-flow fluorescence polarization immunoassay of abused drugs and their metabolites in urine. Pérez-Bendito D; Gómez-Hens A; Gaikwad A Clin Chem; 1994 Aug; 40(8):1489-93. PubMed ID: 8044987 [TBL] [Abstract][Full Text] [Related]
4. Frontline immunochromatographic device for on-site urine testing of amphetamines: laboratory validation using authentic specimens. Beck O; Kraft M; Moeller MR; Smith BL; Schneider S; Wennig R Ann Clin Biochem; 2000 Mar; 37 ( Pt 2)():199-204. PubMed ID: 10735364 [TBL] [Abstract][Full Text] [Related]
5. Lack of Detection of New Amphetamine-Like Drugs Using Conventional Urinary Immunoassays. Begeman A; Franssen EJF Ther Drug Monit; 2018 Feb; 40(1):135-139. PubMed ID: 29194289 [TBL] [Abstract][Full Text] [Related]
6. [The urinary screening and identification of amphetamines in clinical toxicology laboratory--VGH]. Lin WL; Deng JF; Chou LJ; Hung DZ; Tsai WJ Zhonghua Yi Xue Za Zhi (Taipei); 1991 Oct; 48(4):305-9. PubMed ID: 1659927 [TBL] [Abstract][Full Text] [Related]
7. Screening for urinary amphetamine and analogs by capillary electrophoretic immunoassays and confirmation by capillary electrophoresis with on-column multiwavelength absorbance detection. Ramseier A; Caslavska J; Thormann W Electrophoresis; 1998 Nov; 19(16-17):2956-66. PubMed ID: 9870396 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of ephedrine, pseudoephedrine and phenylpropanolamine concentrations in human urine samples and a comparison of the specificity of DRI amphetamines and Abuscreen online (KIMS) amphetamines screening immunoassays. Stout PR; Klette KL; Horn CK J Forensic Sci; 2004 Jan; 49(1):160-4. PubMed ID: 14979364 [TBL] [Abstract][Full Text] [Related]
9. False positive amphetamines and 3,4-methylenedioxymethamphetamine immunoassays in the presence of metoprolol-two cases reported in clinical toxicology. Leclercq M; Soichot M; Delhotal-Landes B; Bourgogne E; Gourlain H; Mégarbane B; Labat L J Anal Toxicol; 2020 Mar; 44(2):200-205. PubMed ID: 31384953 [TBL] [Abstract][Full Text] [Related]
10. Isomeric amphetamines--a problem for urinalysis? Smith FP; Kidwell DA Forensic Sci Int; 1991 Sep; 50(2):153-65. PubMed ID: 1748353 [TBL] [Abstract][Full Text] [Related]
11. Application of the novel immunoassay TRIAGE to a rapid detection of antemortem drug abuse. Röhrich J; Schmidt K; Bratzke H J Anal Toxicol; 1994; 18(7):407-14. PubMed ID: 7861755 [TBL] [Abstract][Full Text] [Related]
12. Structural elucidation of an uncommon phenylethylamine analogue in urine responsible for discordant amphetamine immunoassay results. Marson C; Schneider S; Meys F; Wennig R J Anal Toxicol; 2000; 24(1):17-21. PubMed ID: 10654564 [TBL] [Abstract][Full Text] [Related]
13. Immunoassays of amphetamines: immunogen structure vs antibody specificity. Suttijitpaisal P; Ratanabanangkoon K Asian Pac J Allergy Immunol; 1992 Dec; 10(2):159-64. PubMed ID: 1305818 [TBL] [Abstract][Full Text] [Related]
14. Simultaneous determination of amphetamines and amphetamine-derived designer drugs in human urine by GC-MS. Maresová V; Chadt J; Prikryl L Neuro Endocrinol Lett; 2006 Dec; 27 Suppl 2():121-4. PubMed ID: 17159795 [TBL] [Abstract][Full Text] [Related]
15. Cross-reactivity studies and predictive modeling of "Bath Salts" and other amphetamine-type stimulants with amphetamine screening immunoassays. Petrie M; Lynch KL; Ekins S; Chang JS; Goetz RJ; Wu AH; Krasowski MD Clin Toxicol (Phila); 2013 Feb; 51(2):83-91. PubMed ID: 23387345 [TBL] [Abstract][Full Text] [Related]
16. Cross-reactivity of selected benzofurans with commercial amphetamine and ecstasy immunoassays in urine. Gomila I; Moranta C; Quesada L; Pastor Y; Dastis M; Torrents A; Elorza MÁ; Busardò FP; Barceló B Bioanalysis; 2017 Nov; 9(22):1771-1785. PubMed ID: 28975809 [TBL] [Abstract][Full Text] [Related]
17. Cross-reactivity of stimulants found in sports drug testing by two fluorescence polarization immunoassays. de la Torre R; Badia R; Gonzàlez G; García M; Pretel MJ; Farré M; Segura J J Anal Toxicol; 1996; 20(3):165-70. PubMed ID: 8735197 [TBL] [Abstract][Full Text] [Related]
18. Screening of pharmaceuticals and drugs in synovial fluid of the knee joint and in vitreous humor by fluorescence polarization immunoassay (FPIA). Felscher D; Gastmeier G; Dressler J J Forensic Sci; 1998 May; 43(3):619-21. PubMed ID: 9608699 [TBL] [Abstract][Full Text] [Related]
19. Single-step procedure for gas chromatography-mass spectrometry screening and quantitative determination of amphetamine-type stimulants and related drugs in blood, serum, oral fluid and urine samples. Kankaanpää A; Gunnar T; Ariniemi K; Lillsunde P; Mykkänen S; Seppälä T J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Oct; 810(1):57-68. PubMed ID: 15358308 [TBL] [Abstract][Full Text] [Related]